HIDROFEROL 0.266mg capsule me medication leaflet

A11CC06 calcifediol • Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues

Calcifediolum is a metabolite of vitamin D used for the treatment of vitamin D deficiency and hypocalcemia associated with conditions such as osteoporosis, hypoparathyroidism, or chronic kidney disease. Calcifediolum is an active form of vitamin D that helps regulate calcium and phosphorus levels in the body, essential for bone health and the normal functioning of the nervous and muscular systems.

The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on serum calcium and vitamin D levels, as well as the patient's response to treatment.

Common side effects include hypercalcemia, nausea, constipation, headache, and fatigue. In rare cases, more severe adverse effects such as hypercalciuria or kidney failure may occur.

Calcifediolum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all supplements and medications they are taking to avoid drug interactions. Additionally, regular monitoring is important to prevent complications associated with hypercalcemia.

General data about HIDROFEROL 0.266mg

Substance: calcifediol

Date of last drug list: 01-06-2025

Commercial code: W67593001

Concentration: 0.266mg

Pharmaceutical form: capsule me

Quantity: 5

Product type: generic

Price: 25.78 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FAES FARMA S.A. - SPANIA

Holder: FAES FARMA S.A. - SPANIA

Number: 14472/2022/01

Shelf life: 4 years